Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF): Price and Financial Metrics
Today's Latest Price: $1.89 USD
Dec 4 8:00pm Add CANF to Watchlist Sign Up
CANF Stock Summary The ratio of debt to operating expenses for Can-Fite BioPharma Ltd is higher than it is for about just 4.36% of US stocks. With a price/sales ratio of 332.44, Can-Fite BioPharma Ltd has a higher such ratio than 98.58% of stocks in our set. Revenue growth over the past 12 months for Can-Fite BioPharma Ltd comes in at 1,140.3%, a number that bests 99.31% of the US stocks we're tracking. Stocks that are quantitatively similar to CANF, based on their financial statements, market capitalization, and price volatility, are ONTX, CLDX, ARCT, ADAP, and FIXX. CANF's SEC filings can be seen here. And to visit Can-Fite BioPharma Ltd's official web site, go to www.canfite.com.
CANF Price/Volume Stats
CANF Latest News Stream
All News Types
Loading, please wait...
Latest CANF News From Around the Web
Below are the latest news stories about Can-Fite BioPharma Ltd that investors may wish to consider to help them evaluate CANF as an investment opportunity.
Can-Fite BioPharma Ltd. (CANF) Q2 2020 Earnings Conference Call August 27, 2020 04:15 PM ET Company Participants Pnina Fishman - Chief Executive Officer Motti Farbstein - Chief Financial Officer Conference Call Participants Jason Kolbert - Dawson James Vernon Bernardino - H.C. Wainwright & Co., LLC Presentation Operator Good afternoon, everyone,...
The following slide deck was published by Can-Fite BioPharma Ltd. in conjunction with this event....
Can-Fite Submits Investigational New Drug Application to U.S. FDA for COVID-19 Phase II Study
Can-Fite Completes Development of an Assay to Identify Clinically Active Cannabis Derived Compounds
NEW YORK, July 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CANF, RTIX, JBLU, IBIO, and RUN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
Read More 'CANF' Stories Here
CANF Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.9016 seconds.